Pro Vise Management Group, LLC Gilead Sciences, Inc. Transaction History

Pro Vise Management Group, LLC

$1.25 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$73.27 - $83.09 $245,234 - $278,102	3,347 Added 18.11%	21,831 $1.77 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $961,885 - $1.05 Million	13,009 Added 237.61%	18,484 $1.39 Million
Q2 2023 Aug 24, 2023	BUY	$76.01 - $86.7 $416,154 - $474,682	5,475 New	5,475 $421,000
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $196,536 - $221,359	-3,405 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$57.92 - $72.58 $97,073 - $121,644	-1,676 Reduced 32.99%	3,405 $202,000
Q4 2021 Jan 18, 2022	SELL	$64.88 - $73.64 $13,624 - $15,464	-210 Reduced 3.97%	5,081 $369,000
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $335,819 - $366,930	5,291 New	5,291 $364,000
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $207,540 - $236,803	-3,459 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $1,472 - $1,678	-26 Reduced 0.75%	3,459 $202,000
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $46,388 - $58,325	-747 Reduced 17.65%	3,485 $220,000
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $50,348 - $58,464	696 Added 19.68%	4,232 $326,000
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $34,195 - $43,800	-546 Reduced 13.38%	3,536 $264,000
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $98,592 - $108,448	-1,600 Reduced 28.16%	4,082 $265,000
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $23,441 - $25,875	-375 Reduced 6.19%	5,682 $360,000
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $12,435 - $13,945	-201 Reduced 3.21%	6,057 $409,000
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $16,257 - $18,213	-260 Reduced 3.99%	6,258 $407,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $19,191 - $25,043	317 Added 5.11%	6,518 $408,000
Q3 2018 Nov 05, 2018	BUY	$71.28 - $78.92 $285 - $315	4 Added 0.06%	6,201 $479,000
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $259 - $302	4 Added 0.06%	6,197 $439,000
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $13,038 - $15,895	-179 Reduced 2.81%	6,193 $467,000
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $7,399 - $8,686	104 Added 1.66%	6,372 $457,000
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $451,985 - $535,725	6,268	6,268 $508,000

Others Institutions Holding GILD

# of Institutions

1,942

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.12 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.75 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.6 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.

Account